Jinling Pharmaceutical announced that its branch, Fuzhou Meifeng Pharmaceutical Factory, recently received the “Notice of Acceptance” from the State Drug Administration. The registration and marketing license application for carboxymaltose-iron injection drugs was accepted. The acceptance numbers are CYHS2601839 and CYHS2601840, and the specifications are 2ml: 0.1g and 10ml: 0.5g. This drug is a third-generation intravenous iron agent. Currently, only original imported products are on the market in China, and no generic drugs have been approved.

Jinling Pharmaceutical announced that its branch, Fuzhou Meifeng Pharmaceutical Factory, recently received the “Notice of Acceptance” from the State Drug Administration. The registration and marketing license application for carboxymaltose-iron injection drugs was accepted. The acceptance numbers are CYHS2601839 and CYHS2601840, and the specifications are 2ml: 0.1g and 10ml: 0.5g. This drug is a third-generation intravenous iron agent. Currently, only original imported products are on the market in China, and no generic drugs have been approved.